Bon Secours Mercy Health and Lirio will collaborate to develop personalized programs based on clinical data to improve health-related decision-making for patients at risk for chronic diseases including diabetes and hypertension, Justin McGoldrick, MD, the health system’s chief clinical research and innovation officer, explained in the announcement.
The partners will ultimately commercialize the resulting programs for use by other health systems, and Bon Secours Mercy Health will also implement Lirio’s existing programs for use across the health system.
More articles on AI:
Top 10 AI applications for healthcare in 2020: Accenture report
Physicians see 25% of their work being automated in the future, survey finds
Crouse Health deploys AI-enabled stroke detection
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
